Contact Information
Company Information
Company
Nektar Therapeutics
Annual Revenue
98400000.0
Technologies
Mimecast
Outlook
Microsoft Office 365
Google Cloud Hosting
Drupal
VueJS
Adobe Media Optimizer
New Relic
Google Font API
Taleo
Google Tag Manager
Nginx
WordPress.org
reCAPTCHA
Cedexis Radar
Vimeo
ShareThis
Mobile Friendly
Remote
Keywords
drug development & polymer conjugate chemistry
biotechnology
life sciences
biotechnology: pharmaceutical preparations
health care
biopharmaceutical
novel therapies
immune modulation
autoimmune disorders
chronic inflammatory conditions
immuno-oncology
clinical trials
expanded access
investigational medicines
pipeline
therapeutic benefit
polymer chemistry
scientific publications
medical events
patient care
t regulatory cells
il-15 pathway
nktr-214
nktr-255
rezpeg
peg-csf1
tnfr-2
healthcare conferences
research & development
pharmaceutical partners
stock information
financial filings
corporate governance
investor relations
business development
strategic initiatives
drug development
regulatory expertise
clinical strategy
medical affairs
clinical investigator
biologics
safety & efficacy
patient outcomes
therapeutic agents
integrated solutions
healthcare innovations
drug discovery
life-changing medicines
disease management
treatment advancements
healthcare market
cancer therapies
biopharmaceuticals
clinical-stage
chronic inflammation
pegylation
polymer conjugate technology
rezpegaldesleukin
investigational drugs
regulatory t cells
immunology
patient-centric
innovative therapies
unmet medical needs
partnerships
pharmaceutical collaborations
healthcare providers
patient demographics
chronic diseases
immune system balance
therapeutic benefits
healthcare innovation
r&d pipeline
immune-related diseases
market strategy
patient populations
flexible work culture
employee benefits
corporate challenges
leadership issues
recent collaborations
diabetes research
clinical trial network
health
wellness & fitness
hospital & health care
b2b
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans